MedTrace Logo

Burden of Respiratory Syncytial Virus (RSV) in Children in Sweden (BRICS): A Retrospective Study in Sweden

NCT05622331 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1100000

Last updated 2024-05-14

No results posted yet for this study

Summary

Primary Objective:

-Estimate the hospital-associated healthcare resource use (HCRU), and associated costs, of RSV infection in children in comparison to the non-RSV control cohort (general population) and patients with rhinovirus infection.

Secondary Objectives:

* Describe demographic and clinical patient characteristics of RSV infected children.
* Estimate and compare the incidence of RSV infection and acute respiratory infections (ARIs) in children.
* Estimate the mortality associated with RSV infection in children.
* Estimate the social economic burden of RSV infection in children in relation to parents staying home from work to care for their sick child (VAB leave) in comparison to non-RSV control cohort (i.e. parents to children in the general population).

* Estimate the net days with VAB leave and the compensation disbursed (temporary parental benefit) associated with RSV infection in children.
* Estimate the indirect costs that can be attributed to VAB leave.
* Examine the medium- and long-term complications associated with an RSV diagnosis in children in comparison to the non-RSV control chart (general population) and patients with rhinovirus infection.
* Examine and describe risk factors associated with an RSV infection in children
* Estimate the healthcare resource use (HCRU), and associated costs, of RSV infection in children, for a subset of patients where primary care data is available, in comparison to the non-RSV control cohort (general population).

Conditions

  • Respiratory Syncytial Virus (RSV)

Sponsors & Collaborators

  • Quantify Research

    collaborator UNKNOWN

  • Sanofi Pasteur, a Sanofi Company

    lead INDUSTRY

Principal Investigators

  • Clinical Sciences & Operations · Sanofi

Eligibility

Max Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-07-01
Primary Completion
2024-04-19
Completion
2024-04-19

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05622331 on ClinicalTrials.gov